(Q38692815)

5 September 2017

title

The role of complement system in adipose tissue-related inflammation (English)

1 reference

5 September 2017

0 references

Sonia I Vlaicu

1

1 reference

5 September 2017

Alexandru Tatomir

2

1 reference

5 September 2017

Dallas Boodhoo

3

1 reference

5 September 2017

Stefan Vesa

4

1 reference

5 September 2017

Petru A Mircea

5

1 reference

5 September 2017

Horea Rus

6

1 reference

5 September 2017

publication date

11 January 2016

1 reference

5 September 2017

1 reference

5 September 2017

volume

64

1 reference

5 September 2017

issue

3

1 reference

5 September 2017

page(s)

653-664

1 reference

https://scigraph.springernature.com/pub.10.1007/s12026-015-8783-5

5 September 2017

exact match

0 references

cites work

Complement: a key system for immune surveillance and homeostasis

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Complement and its role in innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Beyond lysis: how complement influences cell fate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

The role of complement activation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Membrane attack by complement: the assembly and biology of terminal complement complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Adipose tissue inflammation: feeding the development of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

The role of the complement system in metabolic organs and metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Complement-mediated adipocyte lysis by nephritic factor sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

The role of complement factor C3 in lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

A new effector of lipid metabolism: complement factor properdin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Complement C3: an emerging risk factor in cardiometabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Complement factor H is expressed in adipose tissue in association with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

High expression of complement components in omental adipose tissue in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Downregulation of complement C3 and C3aR expression in subcutaneous adipose tissue in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Mice lacking C1q are protected from high fat diet-induced hepatic insulin resistance and impaired glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Adaptive expression of microRNA-125a in adipose tissue in response to obesity in mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Up-regulation of the complement system in subcutaneous adipocytes from nonobese, hypertriglyceridemic subjects is associated with adipocyte insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Innate immunity and adipose tissue biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Clinical analysis of selected complement-derived molecules in human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Molecular cloning and characterization of RGC-32, a novel gene induced by complement activation in oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

RGC-32 is a novel regulator of the T-lymphocyte cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Role of response gene to complement 32 in diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Response gene to complement 32 deficiency causes impaired placental angiogenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

RGC32 deficiency protects against high-fat diet-induced obesity and insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Role of complement and complement regulatory proteins in the complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Elevated serum levels of mannose-binding lectin and diabetic nephropathy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

C5b-9-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Molecular basis for a link between complement and the vascular complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Glycation of the complement regulatory protein CD59 is a novel biomarker for glucose handling in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

The complement inhibitor CD59 regulates insulin secretion by modulating exocytotic events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Complement activation in diabetic ketoacidosis brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Acylation stimulating protein: a female lipogenic factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Acylation stimulating protein (ASP), an adipocyte autocrine: new directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

An integrative genomics approach to infer causal associations between gene expression and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Recombinant acylation stimulating protein administration to C3-/- mice increases insulin resistance via adipocyte inflammatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Obesity-inducing diet promotes acylation stimulating protein resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Adipsin is an adipokine that improves β cell function in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Complement C3 is a risk factor for the development of diabetes: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Weight gain in relation to plasma levels of complement factor 3: results from a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Proteomic analysis in type 2 diabetes patients before and after a very low calorie diet reveals potential disease state and intervention specific biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Lifestyle changes followed by bariatric surgery lower inflammatory markers and the cardiovascular risk factors C3 and C4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Low-grade inflammation and insulin resistance independently explain substantial parts of the association between body fat and serum C3: The CODAM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Complement factor 3 is associated with insulin resistance and with incident type 2 diabetes over a 7-year follow-up period: the CODAM Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Possible direct influence of complement 3 in decreasing insulin sensitvity in a cohort of overweight and obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Association of serum C3 levels with the risk of myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Prevalence of metabolic syndrome and pre-metabolic syndrome in health professionals: LATINMETS Brazil study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Complement C3 and cleavage products in cardiometabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Fasting and postprandial plasma concentrations of acylation-stimulation protein (ASP) in lean and obese Pima Indians compared to Caucasians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Acylation stimulating protein but not complement C3 associates with metabolic syndrome components in Chinese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Complement-mediated chronic inflammation is associated with diabetic microvascular complication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Elevated properdin and enhanced complement activation in first-degree relatives of South Asian subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Dietary fat, abdominal obesity and smoking modulate the relationship between plasma complement component 3 concentrations and metabolic syndrome risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

Detection of refolding conformers of complement protein C9 during insertion into membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8783-5

C5b-9 terminal complement complex assembly on apoptotic cells in human arterial wall with atherosclerosis

21 January 2018

1 reference

12 December 2020

Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue

1 reference

12 December 2020

Response gene to complement 32 (RGC-32) in endothelial cells is induced by glucose and helpful to maintain glucose homeostasis.

1 reference

12 December 2020

Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy

1 reference

12 December 2020

Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice

1 reference

12 December 2020

Plasma levels of mannan-binding lectin-associated serine proteases MASP-1 and MASP-2 are elevated in type 1 diabetes and correlate with glycaemic control

1 reference

12 December 2020

Cutaneous vascular deposition of C5b-9 and its role as a diagnostic adjunct in the setting of diabetes mellitus and porphyria cutanea tarda

1 reference

12 December 2020

Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance.

1 reference

12 December 2020

Local activation of the complement system in endoneurial microvessels of diabetic neuropathy

1 reference

12 December 2020

Complement activation in diabetic ketoacidosis and its treatment

1 reference

12 December 2020

Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein

1 reference

12 December 2020

The Complement Abnormalities of Lipodystrophy

1 reference

12 December 2020

The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization.

1 reference

12 December 2020

Adipokines and the immune system: an adipocentric view.

1 reference

12 December 2020

Determination of reference intervals for serum complement C3 and C4 levels in Chinese Han ethnic males

1 reference

12 December 2020

Partial lipodystrophy and familial C3 deficiency

1 reference

12 December 2020

Beta cell dysfunction and insulin resistance

1 reference

12 December 2020

The role of complement activation in atherogenesis: the first 40 years

1 reference

12 December 2020

ASP stimulates glucose transport in cultured human adipocytes

1 reference

12 December 2020

Plasma acylation-stimulating protein in coronary artery disease.

1 reference

12 December 2020

Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study

1 reference

12 December 2020

Penetration of C8 and C9 in the C5b-9 complex across the erythrocyte membrane into the cytoplasmic space

1 reference

12 December 2020

Acylation-stimulating Protein (ASP)/Complement C3adesArg Deficiency Results in Increased Energy Expenditure in Mice

1 reference

12 December 2020

Differentiation-induced production of ASP in human adipocytes

1 reference

12 December 2020

Serum mannose-binding lectin is a strong biomarker of diabetic retinopathy in chinese patients with diabetes

1 reference

12 December 2020

The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane

1 reference

12 December 2020

Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.

1 reference

12 December 2020

Plasma Levels of Acylation-Stimulating Protein Are Strongly Predicted by Waist/Hip Ratio and Correlate with Decreased LDL Size in Men.

1 reference

12 December 2020

Activation of the human terminal complement pathway in atherosclerosis

1 reference

12 December 2020

Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase

1 reference

12 December 2020

Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors

1 reference

12 December 2020

Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by sublytic C5b-9 complement complex in aortic endothelial cells

1 reference

12 December 2020

Acylation stimulating protein stimulates insulin secretion

1 reference

12 December 2020

Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque

1 reference

12 December 2020

Cells carrying C5b-9 complement complexes in human atherosclerotic wall

1 reference

12 December 2020

Ultrastructural localization of the membrane attack complex of complement in human renal tissues

1 reference

12 December 2020

Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study

1 reference

12 December 2020

Increased level of the complement C3 protein in endogenous hypertriglyceridemia

1 reference

12 December 2020

Adipsin and an endogenous pathway of complement from adipose cells.

1 reference

12 December 2020

Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque

1 reference

12 December 2020

10.1007/S12026-015-8783-5

Identifiers

DOI

1 reference

Dimensions Publication ID

5 September 2017

1021391886

0 references

1 reference